Heterologous Boost Following Mycobacterium bovis BCG Reduces the Late Persistent, Rather Than the Early Stage of Intranasal Tuberculosis Challenge Infection

Adults are the leading population affected by tuberculosis (TB) epidemic and death. Developing an effective vaccine against adult TB is urgently needed. Mycobacterium bovis Bacillus Calmette-Guerin (BCG) prime-heterologous boost strategy has been explored extensively to protect adults against primar...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Front Immunol
Auteurs principaux: Wu, Yaqi, Cai, Ming, Ma, Jilei, Teng, Xindong, Tian, Maopeng, Bassuoney, Eman Borham Mohamed Borham, Fan, Xionglin
Format: Artigo
Langue:Inglês
Publié: Frontiers Media S.A. 2018
Sujets:
Immunology
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6218689/
https://ncbi.nlm.nih.gov/pubmed/30425711
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2018.02439
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires